Patients with head and neck cancer enrolled in randomized clinical trials evaluating interventions to improve outcome are much younger and have a very good performance status compared to patients seen in clinical practice, according to a recently published systematic review by investigators in the Netherlands (JAMA Otolaryngol Head Neck Surg. May 19, 2022. Published online ahead of print. doi:10.1001/jamaoto.2022.0890). “Physicians should be […]
